{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:01:41Z","timestamp":1792544501580,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jaad.2018.11.035","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T04:38:41Z","timestamp":1543379921000},"page":"1314-1321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations"],"prefix":"10.1016","volume":"80","author":[{"given":"Raffaele Dante","family":"Caposiena Caro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Botti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Di Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gaziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.11.035_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.det.2010.07.003","article-title":"Hidradenitis suppurativa","volume":"28","author":"Danby","year":"2010","journal-title":"Dermatol Clin"},{"issue":"2 suppl 2","key":"10.1016\/j.jaad.2018.11.035_bib2","first-page":"37","article-title":"Quality-of-life impairment in hidradenitis suppurativa","volume":"151","author":"Franceschini","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2018.11.035_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12788\/j.sder.2017.017","article-title":"Pathophysiology of hidradenitis suppurativa","volume":"36","author":"Hoffman","year":"2017","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2018.11.035_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"van der Zee","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2018.11.035_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendonca","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.11.035_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2018.11.035_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativaacne inversa: a prospective study on 23 patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2018.11.035_bib8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/ced.12933","article-title":"Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up","volume":"41","author":"Dessinioti","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2018.11.035_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CCID.S136730","article-title":"The effect of oral clindamycin and rifampicin combination therapy in patients with hidradenitis suppurativa in Singapore","volume":"11","author":"Ochi","year":"2018","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.11.035_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70309-6","article-title":"Antibiotic side effects","volume":"85","author":"Cunha","year":"2001","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaad.2018.11.035_bib11","series-title":"Antibiotic Resistance Threats in the United States, 2013","year":"2013"},{"key":"10.1016\/j.jaad.2018.11.035_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2014.09.006","article-title":"Update on the antibiotic resistance crisis","volume":"18","author":"Rossolini","year":"2014","journal-title":"Clin Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.jaad.2018.11.035_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.det.2015.08.013","article-title":"Antibiotic treatment of hidradenitis suppurativa","volume":"34","author":"Bettoli","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2018.11.035_bib14","article-title":"Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions","author":"Caposiena Caro","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2018.11.035_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/DSS.0000000000001147","article-title":"Ultrasound evaluation as a complementary test in hidradenitis suppurativa: proposal of a standarized report","volume":"43","author":"Martorell","year":"2017","journal-title":"Dermatol Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2018.11.035_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0001-7310(16)30007-2","article-title":"Ultrasound examination of hidradenitis suppurativa","volume":"106","author":"Martorell","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2018.11.035_bib17","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/dsu.12329","article-title":"Ultrasound in-depth characterization and staging of hidradenitis suppurativa","volume":"39","author":"Wortsman","year":"2013","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2018.11.035_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s15010-015-0773-y","article-title":"Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections","volume":"43","author":"Curis","year":"2015","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.jaad.2018.11.035_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/ejd.2013.2213","article-title":"Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination","volume":"24","author":"Join-Lambert","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2018.11.035_bib20","series-title":"The\u00a0Microbiology of Hidradenitis Suppurativa","year":"2011"},{"key":"10.1016\/j.jaad.2018.11.035_bib21","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1093\/clinids\/5.Supplement_3.S402","article-title":"History of the development of rifampicin","volume":"5","author":"Sensi","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaad.2018.11.035_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0738-081X(02)00328-0","article-title":"Rifampicin in dermatology","volume":"21","author":"Tsankov","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2018.11.035_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01743360","article-title":"Immunomodulating effects of antibiotics: literature review","volume":"24","author":"Van Vlem","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.jaad.2018.11.035_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-2164(04)56004-5","article-title":"Lincosamines: chemical structure, biosynthesis, mechanism of action, resistance and applications","volume":"56","author":"Spizek","year":"2004","journal-title":"Adv Appl Microbiol"},{"key":"10.1016\/j.jaad.2018.11.035_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/426545","article-title":"Nonantimicrobial effects of antibacterial agents","volume":"40","author":"Pasquale","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221832961X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221832961X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:49:13Z","timestamp":1759272553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221832961X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S019096221832961X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.11.035","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}